search
Back to results

Alimentation and Diabetes in Lanzarote - ADILAN: a Pilot Trial (ADILAN)

Primary Purpose

Type 2 Diabetes

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Healthy diet A
Healthy diet B
Sponsored by
Lund University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes focused on measuring Diabetes mellitus type 2, Cereals, Dairy, Dietary carbohydrates, Dietary fiber, Food, Metabolic syndrome, Satiety

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Medical diagnosis of type 2 diabetes
  • Increased waist circumference (≥80 cm for women and ≥94 cm for men)
  • Unaltered medical diabetes treatment since three months before start of study
  • Stable weight (varied less than 5%) since three months before start of study
  • HbA1c ≥6.0%

Exclusion Criteria:

  • Creatinine >130 μmol/L
  • Change of treatment with betablocker last 3 months
  • Change of treatment with thyroid hormone substitution last 3 months
  • Treatment with anticoagulant medication
  • Oral or injected steroid treatment
  • Elevated liver enzymes (AST, ALT, ALP, GPT > 4 times their respective upper reference value)
  • Physical or psychical illness, or changes in personal circumstances that make it impossible for the patient to continue in the study

Sites / Locations

  • Hospital Insular de Lanzarote

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Diet A

Diet B

Arm Description

Healthy diet with grains and dairy

Healthy diet without grains and dairy

Outcomes

Primary Outcome Measures

Fasting fructosamine
Fasting glucagon

Secondary Outcome Measures

Area under the curve for glucose (AUC glucose0-120) at the oral glucose tolerance test
Area under the curve for glucagon (AUC glucagon0-120) at the oral glucose tolerance test
Fasting plasma glucose
Total cholesterol
Low-density lipoprotein (LDL) cholesterol
High-density lipoprotein (HDL) cholesterol
Triglycerides
Systolic and diastolic blood pressure
High-sensitive C-reactive protein
Waist circumference
Hip circumference
Sagittal abdominal diameter
Tricipital, bicipital, suprailiac and subscapular skinfold thickness
Satiation measured on a likert scale at food intake during 4 consecutive days
Quality of life using a validated spanish version of the SF-36 questionnaire
Change in medication
Body weight
Fasting HbA1c

Full Information

First Posted
June 28, 2013
Last Updated
March 20, 2014
Sponsor
Lund University
Collaborators
Cabildo de Lanzarote, Ayuntamiento de Teguise, Ayuntamiento de Arrecife
search

1. Study Identification

Unique Protocol Identification Number
NCT01891955
Brief Title
Alimentation and Diabetes in Lanzarote - ADILAN: a Pilot Trial
Acronym
ADILAN
Official Title
Alimentation and Diabetes in Lanzarote - ADILAN: a Randomized Cross-over Pilot Trial Comparing a Healthy Diet With Grains and Dairy to a Healthy Diet Without Grains and Dairy in Patients With Type 2 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
March 2014
Overall Recruitment Status
Completed
Study Start Date
November 2013 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
February 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Lund University
Collaborators
Cabildo de Lanzarote, Ayuntamiento de Teguise, Ayuntamiento de Arrecife

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to compare two healthy diets (according to official Spanish guidelines) that have been shown to be effective in the treatment of type 2 diabetes in order to see if one is better than the other. Another goal is to test the hypothesis that food choice has metabolic effects that are independent of macro/micronutrient composition, fiber content, glycemic load and weight loss in the treatment of type 2 diabetes.
Detailed Description
There is some uncertainty with respect to the optimal dietary treatment of type 2 diabetes. In addition to energy balance, macronutrient composition, dietary fiber and glycemic load, increasing evidence suggests that the direct endocrine effects of food may be important. In this trial, the intervention is based on two diets. The healthy diet with grains and dairy is based on whole grains, low-fat dairy, fish, shellfish, fruit, vegetables, legumes, eggs, nuts and refined vegetable oils rich in monounsaturated fatty acids (this is called "healthy diet A"). The healthy diet without grains and dairy is based on fish, shellfish, lean meat, fruit, vegetables, root vegetables, eggs and nuts, but excludes grains, legumes, refined vegetable oils, dairy products and salt (this is called "healthy diet B"). Both diets were classified as very healthy using validated nutritional software, and are considered healthy regarding macronutrient composition, fiber, mineral and vitamin intake according to the official Spanish dietary guidelines. The macro and micronutrient ratios, fiber content and glycemic load in healthy diet A and healthy diet B have been set to be equal. The goal is to include 15 patients (>18 years) with medical diagnosis of type 2 diabetes, with or without medication, and increased waist circumference (≥80 cm for women and ≥94 cm for men), to a cross-over trial during two periods of 4-weeks separated by a 6-week washout period. Lunch will be served in a hospital kitchen for control of nutrient intake, while the rest of meals will be eaten at home according to specific directions. The working hypothesis of this study is that food choice has beneficial effects on the control of glucose beyond macro/micronutrient composition, fiber content, glycemic load and weight loss. This study will provide information on whether food choice and diet quality has greater impact than macro/micronutrient composition, fiber content, glycemic load and weight loss in glucose control in patients with type 2 diabetes, and the need to conduct a long-term trial testing our hypothesis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes
Keywords
Diabetes mellitus type 2, Cereals, Dairy, Dietary carbohydrates, Dietary fiber, Food, Metabolic syndrome, Satiety

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
14 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Diet A
Arm Type
Active Comparator
Arm Description
Healthy diet with grains and dairy
Arm Title
Diet B
Arm Type
Active Comparator
Arm Description
Healthy diet without grains and dairy
Intervention Type
Behavioral
Intervention Name(s)
Healthy diet A
Intervention Description
Healthy diet A will include fruit, vegetables, fish, shellfish, lean meat, nuts, eggs and olive oil. Macro/micronutrient composition, fiber intake and glycemic load will not differ from healthy diet B. Healthy diet A will include substantial amounts of whole grains, low-fat dairy and legumes (this is called "healthy diet with grains and dairy"). This diet is classified as very healthy using validated nutritional software. It is in accordance with official Spanish dietary recommendations for people with diabetes type 2 regarding macronutrient composition, dietary fiber, minerals and vitamins.
Intervention Type
Behavioral
Intervention Name(s)
Healthy diet B
Intervention Description
Healthy diet B will include fruit, vegetables, fish, shellfish, lean meat, nuts, eggs and olive oil. Macro/micronutrient composition, fiber intake and glycemic load will not differ from healthy diet A. Healthy diet B will exclude grains, legumes and dairy, which will largely be replaced by root vegetables, vegetables and fruit, and slightly more lean meat, fish and nuts (this is called "healthy diet without grains and dairy"). Salt intake will be lower in healthy diet B. This diet is classified as very healthy using validated nutritional software. It is in accordance with official Spanish dietary recommendations for people with diabetes type 2 regarding macronutrient composition, dietary fiber, minerals and vitamins.
Primary Outcome Measure Information:
Title
Fasting fructosamine
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Title
Fasting glucagon
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Secondary Outcome Measure Information:
Title
Area under the curve for glucose (AUC glucose0-120) at the oral glucose tolerance test
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Title
Area under the curve for glucagon (AUC glucagon0-120) at the oral glucose tolerance test
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Title
Fasting plasma glucose
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Title
Total cholesterol
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Title
Low-density lipoprotein (LDL) cholesterol
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Title
High-density lipoprotein (HDL) cholesterol
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Title
Triglycerides
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Title
Systolic and diastolic blood pressure
Time Frame
To be assessed at baseline and after 4, 10 and 14 weeks
Title
High-sensitive C-reactive protein
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks
Title
Waist circumference
Time Frame
To be assessed at baseline and after 4, 10 and 14 weeks
Title
Hip circumference
Time Frame
To be assessed at baseline and after 4, 10 and 14 weeks
Title
Sagittal abdominal diameter
Time Frame
To be assessed at baseline and after 4, 10 and 14 weeks
Title
Tricipital, bicipital, suprailiac and subscapular skinfold thickness
Time Frame
To be assessed at baseline and after 4, 10 and 14 weeks
Title
Satiation measured on a likert scale at food intake during 4 consecutive days
Time Frame
To be assessed at baseline and after 4, 10 and 14 weeks
Title
Quality of life using a validated spanish version of the SF-36 questionnaire
Time Frame
To be assessed at baseline and after 4, 10 and 14 weeks
Title
Change in medication
Time Frame
To be assessed at baseline and after 4, 10 and 14 weeks
Title
Body weight
Time Frame
To be assessed at baseline and after 4, 10 and 14 weeks
Title
Fasting HbA1c
Time Frame
Laboratory tests will be performed at baseline and after 4, 10 and 14 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Medical diagnosis of type 2 diabetes Increased waist circumference (≥80 cm for women and ≥94 cm for men) Unaltered medical diabetes treatment since three months before start of study Stable weight (varied less than 5%) since three months before start of study HbA1c ≥6.0% Exclusion Criteria: Creatinine >130 μmol/L Change of treatment with betablocker last 3 months Change of treatment with thyroid hormone substitution last 3 months Treatment with anticoagulant medication Oral or injected steroid treatment Elevated liver enzymes (AST, ALT, ALP, GPT > 4 times their respective upper reference value) Physical or psychical illness, or changes in personal circumstances that make it impossible for the patient to continue in the study
Facility Information:
Facility Name
Hospital Insular de Lanzarote
City
Arrecife
State/Province
Las Palmas
ZIP/Postal Code
35500
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
17636747
Citation
Nield L, Moore HJ, Hooper L, Cruickshank JK, Vyas A, Whittaker V, Summerbell CD. Dietary advice for treatment of type 2 diabetes mellitus in adults. Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004097. doi: 10.1002/14651858.CD004097.pub4.
Results Reference
background
PubMed Identifier
23364002
Citation
Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013 Mar;97(3):505-16. doi: 10.3945/ajcn.112.042457. Epub 2013 Jan 30.
Results Reference
background
PubMed Identifier
19604407
Citation
Jonsson T, Granfeldt Y, Ahren B, Branell UC, Palsson G, Hansson A, Soderstrom M, Lindeberg S. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovasc Diabetol. 2009 Jul 16;8:35. doi: 10.1186/1475-2840-8-35.
Results Reference
background
PubMed Identifier
17583796
Citation
Lindeberg S, Jonsson T, Granfeldt Y, Borgstrand E, Soffman J, Sjostrom K, Ahren B. A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia. 2007 Sep;50(9):1795-1807. doi: 10.1007/s00125-007-0716-y. Epub 2007 Jun 22.
Results Reference
background
PubMed Identifier
16336696
Citation
Jonsson T, Olsson S, Ahren B, Bog-Hansen TC, Dole A, Lindeberg S. Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance? BMC Endocr Disord. 2005 Dec 10;5:10. doi: 10.1186/1472-6823-5-10.
Results Reference
background
PubMed Identifier
24383431
Citation
Fontes-Villalba M, Jonsson T, Granfeldt Y, Frassetto LA, Sundquist J, Sundquist K, Carrera-Bastos P, Fika-Hernando M, Picazo O, Lindeberg S. A healthy diet with and without cereal grains and dairy products in patients with type 2 diabetes: study protocol for a random-order cross-over pilot study--Alimentation and Diabetes in Lanzarote--ADILAN. Trials. 2014 Jan 2;15:2. doi: 10.1186/1745-6215-15-2.
Results Reference
derived

Learn more about this trial

Alimentation and Diabetes in Lanzarote - ADILAN: a Pilot Trial

We'll reach out to this number within 24 hrs